Federal contract award
15B20526P00000144
NATIONAL DRUG CODE: 73154-0130.60 GENERIC NAME: TENAPANOR 20MG TAB TRADE NAME: XPHOZAH
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Justice |
| Office | FMC DEVENS |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $2.0K |
| Current contract value | $2.0K |
| Potential contract value / ceiling | $2.0K |
| Start date | Jul 20, 2026 |
| Current end date | Jul 20, 2026 |
| Potential end date | Jul 20, 2026 |
| Latest award activity | Jul 20, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 20, 2026 | 0 | $2.0K | NATIONAL DRUG CODE: 73154-0130.60 GENERIC NAME: TENAPANOR 20MG TAB TRADE NAME: XPHOZAH |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.